Enanta Pharmaceuticals
ENTA · NASDAQ
$11.67+$0.26 (+2.28%)TodayMarket closed ·
Prev close $11.41
EPS: actual vs estimate
Beat the estimate in 6 of the last 8 quarters, by 23.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q3 FY26 | -$0.5202 | -$0.67 | −28.8% |
| Q2 FY26 | -$0.4978 | -$0.45 | +9.6% |
| Q1 FY26 | -$0.8237 | -$0.42 | +49.0% |
| Q4 FY25 | -$1.04 | -$0.87 | +16.5% |
| Q3 FY25 | -$1.30 | -$0.85 | +34.7% |
| Q2 FY25 | -$1.16 | -$1.06 | +8.5% |
| Q1 FY25 | -$1.38 | -$1.05 | +23.9% |
| Q4 FY24 | -$1.18 | -$1.36 | −14.9% |
Earnings calls
- 44th Annual J.P. Morgan Healthcare Conference
- Special Call - Enanta Pharmaceuticals, Inc.
- 43rd Annual J.P. Morgan Healthcare Conference 2025
- Special Call - Enanta Pharmaceuticals, Inc.
- ENTA - Earnings call Q2 2024
- ENTA - Earnings call 1 2024
- J.P. Morgan 42nd Annual Healthcare Conference 2024
- ENTA - Earnings call 4 2023
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.